Trial Profile
A study of solifenacin succinate compared to tolterodine in patients with overactive bladder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2015
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary) ; Tolterodine
- Indications Overactive bladder
- Focus Registrational; Therapeutic Use
- 16 Oct 2006 Status change
- 05 Nov 2005 New trial record.